AMRUTANJAN HEALTH - stock earnings
AMRUTANJAN.NS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 174.5 million INR | 1.2 billion INR |
| 2023Q3 | 68.5 million INR | 993.1 million INR |
| 2023Q2 | 70.1 million INR | 778.6 million INR |
| 2023Q1 | 127.0 million INR | 1.0 billion INR |
| 2022Q4 | 107.1 million INR | 976.5 million INR |
| 2022Q3 | 127.7 million INR | 1.1 billion INR |
| 2022Q2 | 36.6 million INR | 709.5 million INR |
| 2022Q1 | 36.6 million INR | 709.5 million INR |
| 2021Q4 | 205.8 million INR | 1.1 billion INR |
| 2021Q3 | 198.5 million INR | 1.1 billion INR |
| 2021Q2 | 120.6 million INR | 782.1 million INR |
| 2021Q1 | 102.3 million INR | 940.2 million INR |
| 2020Q4 | 209.9 million INR | 1.0 billion INR |
| 2020Q3 | 235.5 million INR | 921.1 million INR |
| 2020Q2 | 64.3 million INR | 466.2 million INR |
| 2020Q1 | 78.9 million INR | 585.6 million INR |
| 2019Q4 | 94.9 million INR | 827.5 million INR |
| 2019Q3 | 84.0 million INR | 748.1 million INR |
| 2019Q2 | -7.0 million INR | 446.0 million INR |
| 2019Q1 | 142.7 million INR | 838.8 million INR |
| 2018Q4 | 52.9 million INR | 702.7 million INR |
| 2018Q3 | 64.9 million INR | 620.5 million INR |
| 2018Q2 | -15.4 million INR | 357.7 million INR |
| 2018Q1 | 57.2 million INR | 746.8 million INR |
| 2017Q4 | 64.3 million INR | 629.4 million INR |
| 2017Q3 | 91.3 million INR | 563.0 million INR |
| 2017Q2 | -15.1 million INR | 317.0 million INR |
| 2017Q1 | 26.3 million INR | 695.5 million INR |
| 2016Q4 | 92.8 million INR | 591.1 million INR |
| 2016Q3 | 71.3 million INR | 555.5 million INR |
| 2013Q1 | 32.3 million INR | 577.5 million INR |
| 2012Q4 | 33.7 million INR | 360.0 million INR |
| 2012Q3 | 32.1 million INR | 288.0 million INR |
| 2012Q2 | 3.0 million INR | 141.0 million INR |
| 2008Q1 | 7.4 million INR | 194.9 million INR |
| 2007Q4 | 7.4 million INR | 196.1 million INR |
| 2007Q3 | 30.4 million INR | 238.6 million INR |
| 2007Q2 | 17.8 million INR | 176.6 million INR |
AMRUTANJAN.NS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 398.3 million INR | 3.8 billion INR |
| 2022 | 671.9 million INR | 4.1 billion INR |
| 2021 | 611.9 million INR | 3.3 billion INR |
| 2020 | 250.8 million INR | 2.6 billion INR |
| 2019 | 250.8 million INR | 2.5 billion INR |
| 2018 | 199.7 million INR | 2.2 billion INR |
| 2017 | 214.1 million INR | 2.2 billion INR |
| 2016 | 205.8 million INR | 1.9 billion INR |
| 2015 | 150.7 million INR | 1.7 billion INR |
| 2014 | 124.4 million INR | 1.4 billion INR |
| 2013 | 101.2 million INR | 1.4 billion INR |
| 2012 | 96.4 million INR | 1.4 billion INR |
| 2011 | 102.1 million INR | 1.1 billion INR |
| 2010 | 114.7 million INR | 897.7 million INR |
| 2009 | 923.9 million INR | 906.6 million INR |
| 2008 | 50.3 million INR | 745.5 million INR |
| 2007 | 59.1 million INR | 723.9 million INR |
AMRUTANJAN.NS
Price: ₹744.95
Dividend Yield: 0.01%
Forward Dividend Yield: 0.54%
Payout Ratio: 26.49%
Dividend Per Share: 4.00 INR
Earnings Per Share: 15.13 INR
P/E Ratio: 45.11
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 21.7 billion
Average Dividend Frequency: 3
Years Paying Dividends: 15
DGR3: 30.00%
DGR5: 30.00%
DGR10: 23.43%